Search research articles
Contact Us
Filters
Showing results (41-50 of 50) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 50 results.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
October 25, 2017
Bioengineered NRF2-siRNA Is Effective to Interfere with NRF2 Pathways and Improve Chemosensitivity of Human Cancer Cells
Peng-Cheng Li, Mei-Juan Tu, Pui Yan Ho, et al.
Biorxiv : the Preprint Server for Biology
|
September 30, 2024
An Iterative Approach to Polish the Nanopore Sequencing Basecalling for Therapeutic RNA Quality Control
Ziyuan Wang, Mei-Juan Tu, Ziyang Liu, et al.
Communications Biology
|
October 1, 2025
A reference-guided iterative approach to polish the nanopore sequencing basecalling for therapeutic RNA quality control
Ziyuan Wang, Mei-Juan Tu, Ziyang Liu, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
May 3, 2015
Chimeric MicroRNA-1291 Biosynthesized Efficiently in Escherichia coli Is Effective to Reduce Target Gene Expression in Human Carcinoma Cells and Improve Chemosensitivity
Mei-Mei Li, Balasubrahmanyam Addepalli, Mei-Juan Tu, et al.
Placenta
|
March 16, 2017
Down-regulation of the placental BCRP/ABCG2 transporter in response to hypoxia signaling
Lissa N Francois, Ludwik Gorczyca, Jianyao Du, et al.
Cancer Letters
|
November 4, 2018
Bioengineered miRNA-1291 prodrug therapy in pancreatic cancer cells and patient-derived xenograft mouse models
Mei-Juan Tu, Pui Yan Ho, Qian-Yu Zhang, et al.
Theranostics
|
March 23, 2021
<i>In vivo</i> fermentation production of humanized noncoding RNAs carrying payload miRNAs for targeted anticancer therapy
Peng-Cheng Li, Mei-Juan Tu, Pui Yan Ho, et al.
Frontiers in Oncology
|
March 13, 2020
The Optimal Outcome of Suppressing Ewing Sarcoma Growth <i>in vivo</i> With Biocompatible Bioengineered miR-34a-5p Prodrug
Dai-Feng Li, Ying Yuan, Mei-Juan Tu, et al.
Oncotarget
|
April 19, 2017
Co-targeting of DNA, RNA, and protein molecules provides optimal outcomes for treating osteosarcoma and pulmonary metastasis in spontaneous and experimental metastasis mouse models
Chao Jian, Mei-Juan Tu, Pui Yan Ho, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 1, 2018
Bioengineered Noncoding RNAs Selectively Change Cellular miRNome Profiles for Cancer Therapy
Pui Yan Ho, Zhijian Duan, Neelu Batra, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 50) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 50 results.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
October 25, 2017
Bioengineered NRF2-siRNA Is Effective to Interfere with NRF2 Pathways and Improve Chemosensitivity of Human Cancer Cells
Peng-Cheng Li, Mei-Juan Tu, Pui Yan Ho, et al.
Biorxiv : the Preprint Server for Biology
|
September 30, 2024
An Iterative Approach to Polish the Nanopore Sequencing Basecalling for Therapeutic RNA Quality Control
Ziyuan Wang, Mei-Juan Tu, Ziyang Liu, et al.
Communications Biology
|
October 1, 2025
A reference-guided iterative approach to polish the nanopore sequencing basecalling for therapeutic RNA quality control
Ziyuan Wang, Mei-Juan Tu, Ziyang Liu, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
May 3, 2015
Chimeric MicroRNA-1291 Biosynthesized Efficiently in Escherichia coli Is Effective to Reduce Target Gene Expression in Human Carcinoma Cells and Improve Chemosensitivity
Mei-Mei Li, Balasubrahmanyam Addepalli, Mei-Juan Tu, et al.
Placenta
|
March 16, 2017
Down-regulation of the placental BCRP/ABCG2 transporter in response to hypoxia signaling
Lissa N Francois, Ludwik Gorczyca, Jianyao Du, et al.
Cancer Letters
|
November 4, 2018
Bioengineered miRNA-1291 prodrug therapy in pancreatic cancer cells and patient-derived xenograft mouse models
Mei-Juan Tu, Pui Yan Ho, Qian-Yu Zhang, et al.
Theranostics
|
March 23, 2021
<i>In vivo</i> fermentation production of humanized noncoding RNAs carrying payload miRNAs for targeted anticancer therapy
Peng-Cheng Li, Mei-Juan Tu, Pui Yan Ho, et al.
Frontiers in Oncology
|
March 13, 2020
The Optimal Outcome of Suppressing Ewing Sarcoma Growth <i>in vivo</i> With Biocompatible Bioengineered miR-34a-5p Prodrug
Dai-Feng Li, Ying Yuan, Mei-Juan Tu, et al.
Oncotarget
|
April 19, 2017
Co-targeting of DNA, RNA, and protein molecules provides optimal outcomes for treating osteosarcoma and pulmonary metastasis in spontaneous and experimental metastasis mouse models
Chao Jian, Mei-Juan Tu, Pui Yan Ho, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 1, 2018
Bioengineered Noncoding RNAs Selectively Change Cellular miRNome Profiles for Cancer Therapy
Pui Yan Ho, Zhijian Duan, Neelu Batra, et al.
Page
of 5